Results 211 to 220 of about 3,132,176 (310)
Novel and emerging cutaneous soft tissue tumours
This review outlines the defining histopathological, immunophenotypic and molecular features of novel and emerging cutaneous soft tissue tumours, including hybrid superficial ALK‐rearranged myxoid spindle cell neoplasm/epithelioid fibrous histiocytoma, superficial neurocristic tumour, ALK‐rearranged epithelioid vascular neoplasm and MITF pathway ...
Saba Shafi, Josephine K Dermawan
wiley +1 more source
Corrigendum to "Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis". [PDF]
europepmc +1 more source
Genetic and regenerative contexts specify distinct soft tissue sarcoma identities from Twist2+ progenitors. [PDF]
Costa AC +6 more
europepmc +1 more source
P‐FMT histologically resembles fibroblastic lipoblastoma and has similar gene fusions, DNA methylation profiles, and benign clinical behaviour, supporting classification of P‐FMT as a morphological variant of lipoblastoma. Aim Paediatric PLAG1‐rearranged fibromyxoid tumour (P‐FMT) is an emerging soft‐tissue neoplasm characterized by predominantly ...
Faizan Malik +9 more
wiley +1 more source
Preoperative Radiotherapy and Local Recurrence in Grade 3 Soft Tissue Sarcoma: A Causal Bayesian Network Analysis. [PDF]
Valle A, Fuchs B, Birbaumer M, Heesen P.
europepmc +1 more source
Merlin CP‐GEP integrates mechanistic insights into a clinically actionable assay to predict SLN metastasis risk and inform personalized management of cutaneous melanoma. ABSTRACT The recent inclusion of the Merlin clinicopathologic–gene expression profile (CP‐GEP) assay in the National Comprehensive Cancer Network (NCCN) Melanoma Guidelines represents ...
Frank Z. Jing, Alexander Meves
wiley +1 more source
Multidisciplinary Practice Patterns and Barriers to Preoperative Radiotherapy for Soft Tissue Sarcoma: A National Multicenter Survey. [PDF]
Qu Y +10 more
europepmc +1 more source
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra +5 more
wiley +1 more source

